- Home
- WEA vs MXCT Comparison
WEA vs MXCT Comparison
Compare WEA & MXCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WEA
- MXCT
- Stock Information
- Founded
- WEA 2002
- MXCT 1999
- Country
- WEA United States
- MXCT United States
- Employees
- WEA N/A
- MXCT N/A
- Industry
- WEA Trusts Except Educational Religious and Charitable
- MXCT Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- WEA Finance
- MXCT Health Care
- Exchange
- WEA Nasdaq
- MXCT Nasdaq
- Market Cap
- WEA 129.9M
- MXCT 148.2M
- IPO Year
- WEA N/A
- MXCT 2021
- Fundamental
- Price
- WEA $11.16
- MXCT $1.41
- Analyst Decision
- WEA
- MXCT Buy
- Analyst Count
- WEA 0
- MXCT 4
- Target Price
- WEA N/A
- MXCT $7.50
- AVG Volume (30 Days)
- WEA 46.1K
- MXCT 1.1M
- Earning Date
- WEA 01-01-0001
- MXCT 11-05-2025
- Dividend Yield
- WEA 7.87%
- MXCT N/A
- EPS Growth
- WEA N/A
- MXCT N/A
- EPS
- WEA N/A
- MXCT N/A
- Revenue
- WEA N/A
- MXCT $35,754,000.00
- Revenue This Year
- WEA N/A
- MXCT N/A
- Revenue Next Year
- WEA N/A
- MXCT $14.79
- P/E Ratio
- WEA N/A
- MXCT N/A
- Revenue Growth
- WEA N/A
- MXCT N/A
- 52 Week Low
- WEA $9.60
- MXCT $1.26
- 52 Week High
- WEA $11.29
- MXCT $5.20
- Technical
- Relative Strength Index (RSI)
- WEA 71.78
- MXCT 37.67
- Support Level
- WEA $10.89
- MXCT $1.32
- Resistance Level
- WEA $11.03
- MXCT $1.44
- Average True Range (ATR)
- WEA 0.08
- MXCT 0.06
- MACD
- WEA 0.01
- MXCT 0.03
- Stochastic Oscillator
- WEA 94.74
- MXCT 56.25
About WEA Western Asset Bond Fund Share of Beneficial Interest
Western Asset Premier Bond Fund is a diversified closed-end management investment company. Its investment objective is to provide current income and capital appreciation by investing in a diversified portfolio of investment-grade bonds. The Fund invests in sectors, such as financials, energy, telecommunication services, consumer discretionary, healthcare, materials, information technology, and consumer staples.
About MXCT MaxCyte Inc.
MaxCyte Inc is a commercial cell engineering company focused on providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics and to support cell-based research and development. The company has developed and commercialized a proprietary Flow Electroporation platform, which facilitates the complex engineering of a wide variety of cells. The Company has one reportable segment, cell engineering technology. The revenue is generated from the sale and licensing of company's instruments, as well as sales of single-use disposable processing assemblies.